Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, has earned a prestigious Merit Extension Award from the National Cancer Institute (NCI), part of the National Institutes of…

Study lays groundwork for clinical trial aimed at preventing brain tumors in children with NF1 A drug used to treat children with epilepsy prevents brain tumor formation and growth in two mouse models of neurofibromatosis…

Using AI to help doctors read mammograms reduces follow-up testing without missing cancer cases, simulation shows Using artificial intelligence (AI) to supplement radiologists’ evaluations of mammograms may improve breast-cancer screening by reducing false positives without…

Apart from not smoking, it’s hard to find something that’s better for us than being physically active. From lowering the risk of heart disease and stroke to boosting mobility to adding healthy years to our…

Strategy effective against some rare, aggressive sarcomas with no other treatment options A clinical trial led by researchers at Washington University School of Medicine in St. Louis has shown that a T cell immunotherapy —…

Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis announces a significant expansion to its Peritoneal Surface Malignancy Program to include a broader multidisciplinary team dedicated to the advanced…

Method may inform personalized cancer treatments Physicians treating patients with early-stage lung cancer face a conundrum: choosing potentially helpful yet toxic therapies such as chemotherapy, radiation or immunotherapy to knock out the cancer and lessen…

School of Medicine leads international team funded by Cancer Grand Challenges Colorectal cancer rates in adults under age 50 have been increasing in the U.S. and globally. The risk of developing such cancers has been…